Obermeyer Wealth Partners’s NovoCure NVCR Stock Holding History

Obermeyer Wealth Partners’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$190K	Hold	12,564	–	–	0.01%	298
2026 Q1	$137K	Buy	+12,564	New	+$157K	0.01%	295

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Obermeyer Wealth Partners's NVCR Position: Q2 2026 in Review

Obermeyer Wealth Partners held its NovoCure (NVCR) position steady in Q2 2026 at 12,564 shares worth $190K. The position accounts for 0.01% of the portfolio, ranked #298.

Obermeyer Wealth Partners first reported a position in NVCR in Q1 2026 and has held it in 2 quarters since. 216 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

Obermeyer Wealth Partners held 12,564 shares of NovoCure worth $190K as of Q2 2026.
Obermeyer Wealth Partners left its NovoCure share count unchanged in Q2 2026.
NovoCure made up 0.01% of Obermeyer Wealth Partners's portfolio in Q2 2026, its #298 holding.
Obermeyer Wealth Partners first reported a position in NovoCure in Q1 2026 and has held it in 2 quarters since.
216 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Obermeyer Wealth Partners's 13F filing for Q2 2026, filed 29 Jul 2026.